These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7860045)
1. p53 accumulation in benign breast biopsy specimens. Younes M; Lebovitz RM; Bommer KE; Cagle PT; Morton D; Khan S; Laucirica R Hum Pathol; 1995 Feb; 26(2):155-8. PubMed ID: 7860045 [TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity with monoclonal antibody A-80 and nuclear DNA content in benign and malignant human breast disease. Eriksson E; Schimmelpenning H; Silfverswärd C; Auer G Hum Pathol; 1992 Dec; 23(12):1366-72. PubMed ID: 1468773 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease. Eriksson ET; Schimmelpenning H; Aspenblad U; Zetterberg A; Auer GU Hum Pathol; 1994 Nov; 25(11):1228-33. PubMed ID: 7959668 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens. Shah VI; Flowers CI; Douglas-Jones AG; Dallimore NS; Rashid M Histopathology; 2006 May; 48(6):683-91. PubMed ID: 16681684 [TBL] [Abstract][Full Text] [Related]
5. p53 expression in cytologic specimens from benign and malignant breast lesions. Koutselini H; Malliri A; Field JK; Spandidos DA Anticancer Res; 1991; 11(4):1415-9. PubMed ID: 1746898 [TBL] [Abstract][Full Text] [Related]
6. [Fine needle aspiration cytology diagnosis of ductal lesions of breast]. Di F; Wong NL Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176 [TBL] [Abstract][Full Text] [Related]
7. p53 mutations in benign breast tissue. Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086 [TBL] [Abstract][Full Text] [Related]
8. Expression of c-erbB-2 oncogene and p53 tumor suppressor gene in benign and malignant breast tissue: correlation with proliferative activity and prognostic index. Alexiev BA; Bassarova AV; Popovska SL; Popov AA; Christov CZ Gen Diagn Pathol; 1997 Jun; 142(5-6):271-9. PubMed ID: 9228249 [TBL] [Abstract][Full Text] [Related]
9. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions. Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies 323/A3 and Ca1 identify a paracrine function of breast carcinoma on adjacent benign histological components. Courtney SP; Williams S; Mansel RE Br J Cancer Suppl; 1990 Jul; 10():92-5. PubMed ID: 1696492 [TBL] [Abstract][Full Text] [Related]
11. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Rejthar A; Kovarík J; Lane DP Int J Cancer; 1990 Nov; 46(5):839-44. PubMed ID: 2228312 [TBL] [Abstract][Full Text] [Related]
12. [Role of immunocytochemistry in fine needle aspiration cytology diagnosis of mammary lesions of breast]. Di F; Wong NL Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):738-43. PubMed ID: 17374259 [TBL] [Abstract][Full Text] [Related]
13. Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy? Koo JS; Han K; Kim MJ; Moon HJ; Kim EK; Park BW Breast Cancer Res Treat; 2013 Feb; 137(3):797-806. PubMed ID: 23292118 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic associations of p53 immunostaining in fine needle aspiration cytology of the breast. Stephenson TJ; Royds JA; Silcocks PB; Brammer HJ; Shorthouse AJ; Underwood JC Cytopathology; 1994 Jun; 5(3):146-53. PubMed ID: 7919057 [TBL] [Abstract][Full Text] [Related]
15. P53 expression in patients with malignant and benign breast diseases. Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875 [TBL] [Abstract][Full Text] [Related]
17. Small Glandular Proliferations of the Breast With Absent or Attenuated Myoepithelial Reactivity by Immunohistochemistry: A Review Focusing on the Differential Diagnosis and Interpretative Pitfalls. Ginter PS; Shin SJ; D'Alfonso TM Arch Pathol Lab Med; 2016 Jul; 140(7):651-64. PubMed ID: 27362570 [TBL] [Abstract][Full Text] [Related]
18. Modified Core Wash Cytology: A reliable same day biopsy result for breast clinics. Bulte JP; Wauters CA; Duijm LE; de Wilt JH; Strobbe LJ Eur J Surg Oncol; 2016 Dec; 42(12):1821-1826. PubMed ID: 27450639 [TBL] [Abstract][Full Text] [Related]
19. [Percutaneous stereotactic biopsy of non-palpable breast lesions using the Advanced Breast Biopsy Instrumentation (ABBI) system: critical evaluation of indication strategies]. Wedegärtner U; Otto U; Buitrago-Tellez C; Bremerich J; Oertli D; Torhorst J; Bongartz G Rofo; 2001 Mar; 173(3):224-8. PubMed ID: 11293864 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody B72.3 in benign breast lesions. Soomro S; Shousha S J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]